Aran Labrijn, PhD

Director, Antibody Research and Technologies at Genmab

Speaker

Dr. Aran F. Labrijn has been working in the field of recombinant antibodies for more than 25 years. He holds a PhD in molecular immunology from the University of Amsterdam (2004). In 2002, he joined Genmab where he is currently a director in the department of antibody research and technology with a focus on understanding antibody biology and Fc-engineering. These studies have led to the development of therapeutic antibody formats, including Genmab’s bispecific antibody technology platform (DuoBody®).